Scott C S, Richards S J, Sivakumaran M, Short M, Child J A, Hunt K M, McEvoy M, Steed A J, Balfour I C, Parapia L A
Yorkshire Leukaemia Diagnostic Unit, Cookridge Hospital, Leeds.
Br J Haematol. 1993 Mar;83(3):505-15. doi: 10.1111/j.1365-2141.1993.tb04678.x.
A survey of 870 different adult blood samples (primarily from patients with non-haematological disorders) found that 269 (31%) had increased proportions (> 25%) and/or absolute numbers (> 1.0 x 10(9)/l) of morphologically-defined large granular lymphocytes (LGL), and/or phenotypically-defined NK-associated (NKa) cells. Of these, 112 were re-analysed at least 6 months after initial presentation and were classified as 'persistent' (92/112) or 'transient' (20/112) according to whether or not the original abnormality was still present. Lymphocyte counts in most patients with persistent abnormalities were within normal limits (18/92) or slightly increased (68/92), with only six having a lymphocytosis exceeding 10.0 x 10(9)/l. With the exception of five persistent LGL expansions in which the granular lymphocytes did not express NKa determinants (designated LGL+NKa-), the remaining 87 cases could be phenotypically grouped according to their primary abnormality as CD8+NKa+ (n = 33), CD4+ NKa+ (n = 14), CD8dim+NKa+ (n = 7) or CD8-NKa+ (n = 33). TCR genotypic studies in 58 patients showed that the 16 patients with rearranged TCR components were restricted to the CD8+NKa+ group and that, in most of these, the CD8+ fraction showed abnormal relative CD16/CD56 expression. Persistent neutropenia (n = 15) also appeared to be associated with primary abnormalities of CD8+NKa+ cells (12/15), with 10 of these additionally showing rearranged TCR genes. In contrast, persistently increased CD8dim+NKa+ and CD8-NKa+ components did not appear to phenotypically differ from their corresponding 'counterparts' in normal bloods or in patients with transient LGL/NKa+ abnormalities. This survey has therefore established that persistent LGL/NKa+ abnormalities are considerably more common than suggested in published work, that a high proportion of patients with expanded CD8+NKa+ components, with quite diverse clinical histories, show evidence of clonal lymphoid populations, and that the clonal nature of such disorders appears to be associated with abnormal NKa phenotypic patterns.
一项对870份不同成人血样(主要来自非血液系统疾病患者)的调查发现,269份(31%)血样中形态学定义的大颗粒淋巴细胞(LGL)和/或表型定义的NK相关(NKa)细胞比例增加(>25%)和/或绝对数量增加(>1.0×10⁹/L)。其中,112份在初次检测后至少6个月进行了重新分析,并根据最初的异常是否仍然存在分为“持续性”(92/112)或“短暂性”(20/112)。大多数持续性异常患者的淋巴细胞计数在正常范围内(18/92)或略有增加(68/92),只有6例淋巴细胞增多超过10.0×10⁹/L。除了5例持续性LGL扩增,其中颗粒淋巴细胞不表达NKa决定簇(称为LGL+NKa-)外,其余87例可根据其主要异常表型分组为CD8+NKa+(n = 33)、CD4+ NKa+(n = 14)、CD8dim+NKa+(n = 7)或CD8-NKa+(n = 33)。对58例患者的TCR基因分型研究表明,16例TCR成分重排的患者仅限于CD8+NKa+组,并且在大多数此类患者中,CD8+部分显示出异常的相对CD16/CD56表达。持续性中性粒细胞减少(n = 15)似乎也与CD8+NKa+细胞的原发性异常有关(12/15),其中10例还显示TCR基因重排。相比之下,持续性增加的CD8dim+NKa+和CD8-NKa+成分在表型上似乎与正常血液或短暂性LGL/NKa+异常患者中的相应“对应物”没有差异。因此,这项调查确定,持续性LGL/NKa+异常比已发表的研究中所表明的更为常见,高比例的CD8+NKa+成分扩增患者,尽管临床病史各异,但都显示出克隆性淋巴细胞群的证据,并且此类疾病的克隆性质似乎与异常的NKa表型模式有关。